Browsing: Clinical Trials & R&D

Merck ADC lung cancer treatment shows nearly 50% tumor shrinkage in mid-stage trial, heading to FDA.

Treeline Biosciences, a biotech company founded by Loxo Oncology’s Josh Bilenker and former Novartis executive Jeff Engelman, has announced the advancement of three cancer drugs into Phase 1 clinical trials. This development is supported by a substantial $200 million……

A biotech co-founded by Nobel laureate David Baker has reeled in an $80 million Series B to get into the clinic early next year with an AI-designed cancer drug.

Alnylam Pharmaceuticals said it will start a Phase 3 cardiovascular outcomes trial of its hypertension therapy zilebesiran this year, despite data showing the drug failed in a mid-stage study.

India’s pharmaceutical industry is advancing from bulk drug production to complex formulations, strengthening its role in the global healthcare ecosystem